COVID-19

Dear Partners,

Necessitated by the unprecedented situation created by Covid-19, several industry events and tradeshows across the world have been postponed or stand cancelled. While we were looking forward to meet you, we at Piramal Pharma Solutions have had to take several precautionary measures to protect both our employees and customers, worldwide.

As we move forward in these extraordinary times, we want to assure you that that we are operational by taking the right safety measures and abundant precautions to ensure that we continue to support you and your patients.

While all of us are working remotely for now, you can schedule a discussion with us and we would be glad to help ensure you meet your pharmaceutical development and supply needs and thereby, your clinical and commercial timelines.

Please feel free to reach out to us at:
Stuart.Needleman@piramal.com

Our best wishes to colleagues, friends and family.

Best Regards,
Piramal Pharma Solutions

PiramalPharma Solutions Logo
Peter DeYoung, CEO, Piramal Global Pharma interacts with Global Business Report on US Biopharmaceuticals 2020
May 29, 2020
Peter DeYoung, CEO, Piramal Global Pharma interacts with Chemica Oggi
Apr 07, 2020
Trends in the CDMO industry for 2020
Feb 21, 2020
CDMOs: Endless Summer?
Nov 28, 2019
The surge continues in pharmaceutical services
Nov 25, 2019
Delivering the ADC Promise - John Fowler
Nov 13, 2019